SpermVital, a genetics technology company within the Geno group, is pleased to announce that its proprietary semen preservation technology has received CSS approval for the U.S. market from the National Association of Animal Breeders (NAAB).
The approval confirms that SpermVital’s semen diluent meets the stringent requirements of the NAAB Certification for Semen Services (CSS) program, including verified antibiotic activity and effective control of bacteria that may occur in bovine semen doses. More information about the CSS program is available through NAAB https://www.naab-css.org/about-css.
This milestone represents an important step forward for SpermVital and opens new opportunities for both the company and its customers. With this approval, SpermVital technology is now accessible to a wider range of customers, enabling semen doses to be exported to the United States and further strengthening the company’s foundation for continued global growth.
“As part of Geno, the breeding and genetics company behind Norwegian Red, SpermVital plays an important role in supporting our ambition to deliver high‑quality, sustainable genetic solutions globally.“ - Ton van de Goor, VP International Sales for Geno Global
The CSS approval strengthens access to the U.S. market for genetics associated with Norwegian Red and reinforces the breed’s international position in modern dairy and beef production systems.
SpermVital looks forward to contributing to improved reproductive efficiency for U.S. cattle producers by making long‑lasting, high‑quality semen doses available to the market.
For more information about SpermVital visit SpermVital
